Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -288,249 | -109,328 | 28,242 | 30,114 | 13,993 |
| Depreciation Amortization | 16,718 | 10,900 | 6,390 | 18,139 | 12,997 |
| Accounts receivable | -1,907 | -8,861 | -212,046 | -56,967 | -9,841 |
| Accounts payable and accrued liabilities | 9,980 | 13,073 | 15,263 | 6,286 | 21,662 |
| Other Working Capital | 80,850 | 126,361 | -61,793 | -18,235 | 20,125 |
| Other Operating Activity | 103,062 | 65,778 | 237,425 | 200,215 | 100,125 |
| Operating Cash Flow | $-79,546 | $97,923 | $13,481 | $179,552 | $159,061 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,089,926 | 148,266 | 115,339 | -796,258 | -774,616 |
| PPE Investments | -8,567 | -4,713 | -2,148 | -22,666 | -15,177 |
| Purchase Of Investment | N/A | -1,061,577 | -136,933 | N/A | N/A |
| Sale Of Investment | 224,152 | N/A | N/A | 689,630 | 587,880 |
| Investing Cash Flow | $-874,341 | $-918,024 | $-23,742 | $-129,294 | $-201,913 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | N/A | N/A | 10,260 | 7,098 |
| Debt Issued | 700,000 | 700,000 | N/A | N/A | 0 |
| Debt Repayment | -117,891 | -84,506 | -66,680 | -201,625 | -201,625 |
| Common Stock Issued | 318,870 | 286,976 | 51,930 | 270,371 | 269,864 |
| Common Stock Repurchased | -15,431 | N/A | N/A | N/A | N/A |
| Dividend Paid | -38,434 | -41,514 | N/A | N/A | N/A |
| Other Financing Activity | -66,596 | -79,989 | 0 | -5,000 | -5,000 |
| Financing Cash Flow | $780,518 | $780,967 | $-14,750 | $74,006 | $70,337 |
| Exchange Rate Effect | 1,580 | 1,103 | 106 | -401 | -377 |
| Beginning Cash Position | 226,548 | 226,548 | 226,548 | 102,685 | 102,685 |
| End Cash Position | 54,759 | 188,517 | 201,643 | 226,548 | 129,793 |
| Net Cash Flow | $-171,789 | $-38,031 | $-24,905 | $123,863 | $27,108 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,546 | 97,923 | 13,481 | 179,552 | 159,061 |
| Capital Expenditure | -8,567 | -4,713 | -2,148 | -22,666 | -15,177 |
| Free Cash Flow | -88,113 | 93,210 | 11,333 | 156,886 | 143,884 |